@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: hgnc:5395; a Protein: . sub:_2 geneProductOf: hgnc:11998; a Protein: . sub:_3 occursIn: obo:CLO_0009454, species:9606; rdf:object sub:_2; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "p(HGNC:IFI16) -| p(HGNC:TP53)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "from full text - Fig 6 - reduction of endogenous IFI16 protein level by IFI16 siRNA in U2OS cells resulted in increased protein stability of p53 and p21. U2OS cells were transfected with control siRNA or IFI16 siRNA, and then 72 h after siRNA transfection, cells were chased with CHX (25 ?g/ml) to inhibit de novo protein synthesis. "; prov:wasQuotedFrom pubmed:12925527 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12925527; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:07.325+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }